Executive Summary
Across the 8 S&P 500 Technology stream filings, dominant themes include robust revenue growth in core software players like Snowflake (29% YoY to $4.68B) contrasted with persistent operating losses and slight net retention declines, signaling scaling challenges amid high R&D and sales spend; governance and compensation disclosures in proxies like Cogent reveal mixed incentive achievements (152% AWR CAGR target hit but 79% GP) and large LTIP grants up to 551k RSUs for CEO, indicating long-term alignment. SPAC and name-change activities (dMY to Horizon Quantum, Muzero unit separation, AParadise merger promo) highlight quantum and tech-enabled merger momentum, though with unproven models and regulatory risks. Neutral proxy solicitations in non-core names like Genco and funds show routine governance without financial trends, while limited period-over-period data points to portfolio-level revenue acceleration (e.g., Snowflake's 42% RPO growth outlier) but stable-to-compressing margins (Snowflake gross 67% flat YoY, opex % improving modestly). Overall, mixed sentiment prevails with bullish growth signals outweighed by profitability concerns, creating opportunities in high-growth tech names ahead of catalysts like LTIP vesting and meetings. Critical implications: Investors should prioritize Snowflake's RPO momentum and Cogent's insider-aligned comp over SPAC risks, watching for Q1 2026 earnings to validate trends.
Tracking the trend? Catch up on the prior S&P 500 Technology Sector SEC Filings digest from March 19, 2026.
Investment Signals(12)
- Snowflake Inc.↓(BULLISH)▲
FY2026 revenue surged 29% YoY to $4.68B (product rev +29% to $4.47B), RPO expanded 42% YoY to $9.77B, $1M+ ACV customers +27% to 733, OCF +27% to $1.22B
- Snowflake Inc.↓(BULLISH)▲
Sales/marketing % of rev improved to 44% from 46% YoY, R&D % declined to 42% from 49% YoY, op loss narrowed to $1.44B from $1.46B despite scale
- Cogent Communications↓(BULLISH)▲
CEO LTIPs for 2026 include 229k time-based RSUs vesting 2029 and 321k perf-based on EBITDA CAGR thru 2028 (total notional $12M), signaling mgmt conviction
- Cogent Communications↓(BULLISH)▲
2025 incentives hit 152% of AWR CAGR target ($333.5k earned), non-CEO base salaries +2.5%, full director attendance at 2025 AGM
- dMY Squared (Horizon Quantum)(BULLISH)▲
Name change to Horizon Quantum Inc. with 10k common/500 preferred shares authorized, forum selection in MA courts enhances governance clarity for quantum tech play
- Snowflake Inc.↓(BULLISH)▲
Gross margin stable at 67% YoY, NRR slight dip to 125% from 126% but outperforms prior FY2024's 133% decline trajectory
- AParadise Acquisition Corp.↓(BULLISH)▲
SPAC merger with Enhanced Games progressing post-Nov 2025 announcement, S-4 filed, promo highlights FDA peptide shift potential for May 24 2026 Vegas event
- Muzero Acquisition Corp.↓(BULLISH)▲
Unit separation from Mar 23 2026 enables separate trading of MUZE shares and MUZEW warrants ($11.50 exercise), boosting liquidity for tech-targeted SPAC
- Cogent Communications↓(BULLISH)▲
Independent directors (all except CEO) per Nasdaq, sales commissions at 92% for Mark Harris ($141.9k), LTIPs mix time/perf-based thru 2027-2029
- Snowflake Inc.↓(BULLISH)▲
Customer growth drives RPO outperformance (42% YoY vs revenue 29%), positioning for multi-year backlog in cloud data platform
- Genco Shipping↓(NEUTRAL-BULLISH)▲
Multiple Form 4 insider filings (May-Nov 2025, Feb 2026) ahead of 2026 proxy, no sales noted, supports monitoring mgmt conviction
- AllianceBernstein Funds(NEUTRAL-BULLISH)▲
Directors attended >=75% meetings in FY2025 (ANMIF Board 6x, Audit 4x), routine governance ahead of Mar 30 2026 joint AGM
Risk Flags(10)
- Snowflake Inc./Profitability↓[HIGH RISK]▼
Net loss widened 4% YoY to $1.33B, op loss $1.44B with $1.60B stock comp, high opex (S&M 44%, R&D 42% of rev) despite revenue growth
- Snowflake Inc./Retention↓[MEDIUM RISK]▼
NRR declined to 125% from 126% YoY and 133% FY2024, signaling potential customer churn amid competition
- Cogent Communications/Comp Performance↓[MEDIUM RISK]▼
CEO 2025 incentives only 79% of GP CAGR target ($196.7k), mixed LTIP hits vs targets
- Cogent Communications/Governance↓[MEDIUM RISK]▼
CEO Dave Schaeffer only non-independent director, heavy LTIP reliance (551k RSUs) ties pay to future CAGR
- AParadise Acquisition Corp./Business Model↓[HIGH RISK]▼
Enhanced Games unproven with limited history/revenue, risks from FDA peptide regs despite promo of shift
- Community West Bancshares/Disclosure↓[LOW-MEDIUM RISK]▼
8-K Item 8.01 other events with no details on impacts, voluntary filing raises opacity concerns
- Snowflake Inc./Scale↓[MEDIUM RISK]▼
Gross margin flat 67% YoY despite 29% rev growth, R&D spend cut insufficient to stem $1.33B net loss widening
- Genco Shipping/Proxy↓[MEDIUM RISK]▼
DEFA14A solicits WHITE proxy for 2026 AGM, potential contest implied, review prior ownership via SEC filings
- AllianceBernstein Funds/Attendance[LOW RISK]▼
Mr. Chaloff <75% ANMIF Board meetings in FY2025, joint AGM Mar 30 2026 to watch governance
- Muzero Acquisition Corp./SPAC↓[LOW RISK]▼
Routine unit separation but no financials, target tech but dilution risk from warrants at $11.50 exercise
Opportunities(10)
- Snowflake Inc./RPO Growth↓(OPPORTUNITY)◆
42% YoY RPO to $9.77B vs 29% revenue, $1M+ customers +27%, enter ahead of FY2027 guidance inflection
- Cogent Communications/LTIP Alignment↓(OPPORTUNITY)◆
$12M notional 2026 RSUs (551k shares) for CEO on EBITDA/FCF CAGR thru 2028, undervalued if targets met
- Horizon Quantum/Name Change(OPPORTUNITY)◆
Rebrand from dMY Squared signals quantum focus, MA domicile with defined forums reduces litigation risk, early positioning
- AParadise Acquisition Corp./Merger↓(OPPORTUNITY)◆
APAD shares trading post-S-4, Enhanced Games May 24 2026 event + telehealth/peptides upside if FDA loosens
- Snowflake Inc./Opex Efficiency↓(OPPORTUNITY)◆
S&M -200bps YoY to 44%, R&D -700bps to 42%, OCF +27% to $1.22B sets path to breakeven
- Muzero Acquisition Corp./Liquidity↓(OPPORTUNITY)◆
Separate trading Mar 23 2026 enhances MUZE/MUZEW liquidity, SPAC targeting tech-enabled firms pre-deal
- Cogent Communications/Exec Retention↓(OPPORTUNITY)◆
Sales commish 92% for Harris ($141.9k) vs 77% prior CRO, 2.5% base hikes signal stable leadership
- Snowflake Inc./Customer Expansion↓(OPPORTUNITY)◆
733 $1M+ ACV accounts +27% YoY, net retention near-peaks positions for enterprise wallet share gains
- Genco Shipping/Proxy Review↓(OPPORTUNITY)◆
Recent Form 4s (9 filings 2025-2026), ownership details in prior proxies offer insight pre-2026 AGM
- AllianceBernstein Funds/AGM(OPPORTUNITY)◆
Joint Mar 30 2026 meeting post-strong attendance, potential for fund updates in muni/high income space
Sector Themes(6)
- Revenue Momentum in Cloud/Software◆
Snowflake's 29% YoY rev (+29% product) standout vs limited peers, RPO +42% signals backlog strength (1/8 filings), bullish for S&P tech growth but watch NRR dips
- Mixed Compensation Outcomes◆
Cogent LTIPs hit 152% one target/79% another, large 2026 grants ($12M), reflects uneven execution in comms/tech services (2/8 filings), ties pay to future CAGR
- SPAC Activity Surge◆
3/8 filings (dMY Quantum rebrand, Muzero separation Mar 23, AParadise merger/S-4) target quantum/tech-enabled, liquidity/deal progress but unproven revenue risks
- Governance Focus Pre-AGMs◆
Proxies (Cogent DEF14A, Genco/Alliance DEFA14A) highlight independence, attendance >75% mostly, insider Form 4 clusters (Genco 9 filings), routine but monitor ownership
- Persistent Losses Despite Growth◆
Snowflake op/net losses ($1.44B/$1.33B) widen slightly YoY amid high comp/opex, flat margins (67%), common tech scaling pain (1 core filing)
- Neutral Event Disclosures◆
4/8 neutral sentiment (Genco, Alliance, Community 8-K, Muzero), low materiality avg 5/10, limited PoP but flag opacity in voluntary filings
Watch List(8)
Post-10-K RPO momentum (42% YoY), watch Q1 earnings for NRR stabilization and opex leverage targets [Q2 2026]
551k RSUs on EBITDA/FCF CAGR thru 2028, monitor 2026 performance vs 2025 mixed hits [Ongoing thru 2029]
S-4 progress, Enhanced Games May 24 2026 Vegas event, FDA peptide regs shift [May 2026]
- AllianceBernstein Funds/Joint AGM👁
Mar 30 2026 meeting, director attendance and FY2025 review (ended Oct 31) [Mar 30 2026]
Unit separation liquidity from Mar 23 2026, watch SPAC tech target announcement [Post-Mar 23 2026]
DEFA14A WHITE card solicitation, review Form 4 ownership (latest Feb 2026) pre-AGM [Upcoming 2026 AGM]
- Horizon Quantum/Governance👁
New MA articles/forum selection, track quantum strategy post-rebrand [Ongoing]
Item 8.01 other events undisclosed, watch for 10-Q details on impacts [Next quarterly filing]
Filing Analyses(8)
20-03-2026
Cogent Communications Holdings, Inc.'s DEF 14A proxy statement details corporate governance practices, including full attendance by directors at the 2025 annual meeting and independence of all directors except CEO Dave Schaeffer. For 2025 executive compensation, base salaries for non-CEO Named Executive Officers increased 2.5%, CEO incentives achieved 152% of AWR CAGR target ($333,500 earned) but only 79% of GP CAGR target ($196,743), and sales commissions reached 92% for Mark Harris ($141,900) while at 77% for former CRO James Bubeck ($80,813). Significant long-term incentive grants were awarded, including up to 551,177 RSU shares for the CEO for 2026 service based on $12M notional value.
- ·All directors except CEO determined independent per Nasdaq rules.
- ·CEO 2025 LTIPs: 84,000 time-based RSUs and 96,000 performance-based RSUs (half EBITDA CAGR, half Free Cash Flow CAGR through 2027).
- ·CEO 2026 LTIPs: 229,657 time-based RSUs vesting 2029 and 321,520 performance-based RSUs based on EBITDA CAGR through 2028.
- ·Supplemental 100,000 time-based RSUs each to Chang, Harris, Weed vesting 2029 for Sprint acquisition retention.
- ·Performance-based RSUs for Weed, Chang, Kilmer based on customer satisfaction or performance through 2028.
20-03-2026
dMY Squared Technology Group, Inc. filed Second Amended and Restated Articles of Organization on March 20, 2026, changing its name to Horizon Quantum, Inc., with adoption dated March 19, 2026. The updated articles authorize 10,000 shares of common stock and 500 shares of preferred stock, each with a par value of $0.0001, under Massachusetts law. No financial performance metrics or period-over-period comparisons are provided in the filing.
- ·Registered office: 44 School Street, Suite 505, Boston, Massachusetts 02108
- ·Forum selection: Business Litigation Session of the Superior Court for Suffolk County, Massachusetts, and U.S. District Court for the District of Massachusetts in Boston for certain corporate disputes
20-03-2026
Snowflake Inc. reported FY2026 total revenue of $4.68B, up 29% YoY from $3.63B, driven by 29% product revenue growth to $4.47B, strong operating cash flow of $1.22B (up 27% YoY), and RPO expansion to $9.77B (up 42% YoY), alongside customer growth with $1M+ ACV customers rising 27% to 733. However, net retention rate declined to 125% from 126% YoY and 133% in FY2024, operating loss narrowed slightly to $1.44B from $1.46B but remained elevated, and net loss attributable to Snowflake widened 4% YoY to $1.33B amid high operating expenses and $1.60B in stock-based compensation.
- ·Gross margin stable at 67% in FY2026 vs FY2025.
- ·Sales and marketing expenses as % of revenue improved to 44% from 46% YoY.
- ·Research and development expenses as % of revenue declined to 42% from 49% YoY.
- ·Net cash used in financing activities increased to $1.39B in FY2026 from $0.23B.
20-03-2026
Genco Shipping & Trading Ltd (GNK) filed a DEFA14A on March 20, 2026, announcing its intent to file a definitive proxy statement on Schedule 14A and accompanying WHITE proxy card with the SEC for the 2026 Annual Meeting of Shareholders. The filing discloses participants in the proxy solicitation, including independent directors (Paramita Das, Kathleen C. Haines, Basil G. Mavroleon, Karin Y. Orsel, Arthur L. Regan) and executives (John C. Wobensmith, Peter Allen, Joseph Adamo, Jesper Christensen), with references to prior SEC filings for ownership details. Shareholders are strongly encouraged to review these materials available on SEC.gov and the company's investor relations website at https://investors.gencoshipping.com/.
- ·Prior proxy statement for 2025 Annual Meeting filed with SEC on April 9, 2025.
- ·Form 4 filings for directors and executives on dates including May 22, 2025; June 3, 2025; August 26, 2025; September 10, 2025; September 15, 2025; November 12, 2025; November 26, 2025; February 18, 2026; February 23, 2026.
- ·Investor contact: Peter Allen at (646) 443-8550; Media contact: Leon Berman at (212) 477-8438.
20-03-2026
Additional proxy materials for the Joint Annual Meeting of Stockholders of AllianceBernstein National Municipal Income Fund (ANMIF) and AllianceBernstein Global High Income Fund (AGHIF), scheduled for March 30, 2026. In FY 2025 (ended 2025), AGHIF's Board and Audit Committee each met 4 times, while ANMIF's Board met 6 times and Audit Committee 4 times. All Directors attended at least 75% of meetings, however Mr. Chaloff attended less than 75% of ANMIF Board meetings.
- ·Fiscal year end: October 31
- ·Filing date: March 20, 2026
- ·Joint Annual Meeting date: March 30, 2026
20-03-2026
Muzero Acquisition Corp, a blank check company (SPAC), announced on March 20, 2026, that commencing March 23, 2026, holders of its units (MUZEU) may elect to separately trade Class A Ordinary Shares (MUZE, par value $0.0001) and redeemable warrants (MUZEW, exercisable at $11.50 per share) on Nasdaq. Unseparated units will continue trading as MUZEU, with no fractional warrants issued upon separation. This routine post-IPO event enhances liquidity for components without reported financial impacts.
- ·Company is a SPAC targeting technology-enabled businesses across industries.
- ·Brokers must contact Continental Stock Transfer & Trust Company to separate units.
20-03-2026
Christian Angermayer, Chairman of Enhanced Ltd, emailed sophisticated investors on March 19, 2026, promoting the proposed SPAC merger with A Paradise Acquisition Corp. and highlighting Enhanced Games' potential to capitalize on a possible U.S. regulatory shift loosening FDA restrictions on 14 of 19 prohibited peptides, via its sports event (first in Las Vegas on May 24, 2026), telehealth platform, and performance data collection. The merger, announced in November 2025, is progressing with APAD shares trading. However, forward-looking risks emphasize Enhanced’s unproven business model, limited operating history, and minimal revenue to date.
- ·SPAC ticker: APAD (trust shares trading for early participation)
- ·Merger announced November 2025
- ·Form S-4 registration statement filed with SEC
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 8 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)